Adelene Q Perkins

CIK 1375124 · Chief Executive Officer · last filed 2026-02-18

Adelene Q Perkins is a Chief Executive Officer who has filed 53 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing, for BRKRP, was dated Feb 18, 2026. Across all open-market trades the lifetime net is −$1.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $13.0M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$13.03M

Companies

3

Total Filings

53

Lifetime Open-Market Net

-$1.63M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BRKRP Director 29,144 $401.31 $11.70M $0 1 2026-02-18
BRKR Director 24,624 $54.23 $1.34M $0 9 2025-02-19
INFINITY PHARMACEUTICALS, INC. (INFI) Delisted Chief Executive Officer 1,601,933 $0.04 $71.6K -$1.63M 43 2023-09-12

Recent Filings

53 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-02-18 BRKRP Grant (A) +4,520 $0 EDGAR
2025-02-19 BRKR Grant (A) +3,298 $0 EDGAR
2024-01-09 BRKR Grant (A) +2,377 $0 EDGAR
2023-09-12 INFINITY PHARMACEUTICALS, INC. (INFI) Delisted Mixed +357,937 -$28.7K EDGAR
2023-01-09 BRKR Grant (A) +1,970 $0 EDGAR
2022-01-12 INFINITY PHARMACEUTICALS, INC. (INFI) Delisted Grant (A) $0 EDGAR
2022-01-06 BRKR Grant (A) +1,841 $0 EDGAR
2021-01-07 BRKR Grant (A) +2,302 $0 EDGAR
2020-12-23 INFINITY PHARMACEUTICALS, INC. (INFI) Delisted Grant (A) $0 EDGAR
2020-01-13 INFINITY PHARMACEUTICALS, INC. (INFI) Delisted Grant (A) +155,134 $0 EDGAR
Showing 110 of 53
Page 1 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.